The Q3 EBITDA was even more clearly better than expected than in Q2, rising by 4% yoy despite a 2% decline in revenues.
We maintain our positive stance on the stock with near-20% upside. The group offers a 5.75% dividend yield which is below its peers, while the dividend is in no danger given the control over capex.

22 Oct 2020
EBITDA still on the rise despite the Covid impact on revenues

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
EBITDA still on the rise despite the Covid impact on revenues
The Q3 EBITDA was even more clearly better than expected than in Q2, rising by 4% yoy despite a 2% decline in revenues.
We maintain our positive stance on the stock with near-20% upside. The group offers a 5.75% dividend yield which is below its peers, while the dividend is in no danger given the control over capex.